Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue: +8.50%
EPS: +24.6%
Free cash flow: −16.6%

Quarter to September 2026, against a year earlier

656.11 21.13 +3.33%

Follow MEDP

Alert me

Market cap: $17.8B
P/E: 34.6×
Fwd P/E: 35.8×
Dividend yield: —
F-score: 8/9
Altman Z: 8.04
Beneish M: −2.92
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medpace Holdings, Inc. 10-Q filed Oct 22, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed Oct 22, 2026 · accepted 4:02 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 23, 2026: no changes